Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Pharma's day on the Hill, biotech's paucity of M&A, and the gathering storm of biosimilars
Fierce editors discuss a bizarre congressional hearing, how biotech's slump affects the buyout climate, and a major development in the world of biosimilars.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
